The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A1C and Survival in Maintenance Hemodialysis Patients
Open accessAbstract
OBJECTIVE—The optimal target for glycemic control has not been established in diabetic dialysis patients. RESEARCH DESIGN AND METHODS—To address this question, the national database of a large dialysis organization (DaVita) was analyzed via time-dependent survival models with repeated measures. RESULTS—Of 82,933 patients undergoing maintenance hemodialysis (MHD) in DaVita outpatient clinics over 3 years (July 2001 through June 2004), 23,618 diabetic MHD patients had A1C measurements at least once. Unadjusted survival analyses indicated paradoxically lower death hazard ratios (HRs) with higher A1C values. However, after adjusting for potential confounders (demographics, dialysis vintage, dose, comorbidity, anemia, and surrogates of malnutrition and inflammation), higher A1C values were incrementally associated with higher death risks. Compared with A1C in the 5–6% range, the adjusted all-cause and cardiovascular death HRs for A1C ≥10% were 1.41 (95% CI 1.25–1.60) and 1.73 (1.44–2.08), respectively (P < 0.001). The incremental increase in death risk for rising A1C values was monotonic and robust in nonanemic patients (hemoglobin >11.0 g/dl). In subgroup analyses, the association between A1C >6% and increased death risk was more prominent among younger patients, those who had undergone dialysis for >2 years, and those with higher protein intake (>1 g · kg−1 · day−1), blood hemoglobin (>11 g/dl), or serum ferritin values (>500 ng/ml). CONCLUSIONS—In diabetic MHD patients, the apparently counterintuitive association between poor glycemic control and greater survival is explained by such confounders as malnutrition and anemia. All things equal, higher A1C is associated with increased death risk. Lower A1C levels not related to malnutrition or anemia appear to be associated with improved survival in MHD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,247
Self-citationMalnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
Kalantar-Zadeh, K., Ikizler, T. A., Block, G., Avram, M. M., & Kopple, J. D. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.016 · Cited by 1,040
Self-citationKhaw, K.-T. (2001) · BMJ · doi:10.1136/bmj.322.7277.15 · Cited by 1,017
Kalantar-Zadeh, K., Block, G., Horwich, T., & Fonarow, G. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.039 · Cited by 684
Self-citationSurvival advantages of obesity in dialysis patients
Kalantar-Zadeh, K., Abbott, K. C., Salahudeen, A. K., Kilpatrick, R. D., & Horwich, T. B. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.543 · Cited by 610
Self-citationIV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
(2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)70008-x · Cited by 400
Kalantar-Zadeh, K., McAllister, C. J., Lehn, R. S., Lee, G. H., Nissenson, A. R., & Kopple, J. D. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00915-6 · Cited by 304
Self-citationKalantar-Zadeh, K., Kopple, J. D., Kilpatrick, R. D., McAllister, C. J., Shinaberger, C. S., Gjertson, D. W., & Greenland, S. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.020 · Cited by 290
Self-citationDiabetes education and care management significantly improve patient outcomes in the dialysis unit
McMurray, S. D., Johnson, G., Davis, S., & McDougall, K. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34915 · Cited by 235
Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race
Kilpatrick, R. D., McAllister, C. J., Kovesdy, C. P., Derose, S. F., Kopple, J. D., & Kalantar-Zadeh, K. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070795 · Cited by 233
Self-citationKalantar-Zadeh, K., Kilpatrick, R. D., McAllister, C. J., Greenland, S., & Kopple, J. D. (2005) · Hypertension · doi:10.1161/01.hyp.0000154895.18269.67 · Cited by 226
Self-citationGlycemic Control Is a Predictor of Survival for Diabetic Patients on Hemodialysis
Morioka, T., Emoto, M., Tabata, T., Shoji, T., Tahara, H., Kishimoto, H., Ishimura, E., & Nishizawa, Y. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.909 · Cited by 222
Advanced glycation end products and mortality in hemodialysis patients
Schwedler, S. B., Metzger, T., Schinzel, R., & Wanner, C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00423.x · Cited by 195
Impact of Glycemic Control on Survival of Diabetic Patients on Chronic Regular Hemodialysis
Oomichi, T., Emoto, M., Tabata, T., Morioka, T., Tsujimoto, Y., Tahara, H., Shoji, T., & Nishizawa, Y. (2006) · Diabetes Care · doi:10.2337/dc05-1887 · Cited by 191
Williams, M. E., Lacson, E., Teng, M., Ofsthun, N., & Lazarus, J. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001789 · Cited by 181
Kimmel, P. L., Varela, M. P., Peterson, R. A., Weihs, K. L., Simmens, S. J., Alleyne, S., Amarashinge, A., Mishkin, G. J., Cruz, I., & Veis, J. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00941.x · Cited by 176
Eshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.008 · Cited by 145
Wu, M.-S., Yu, C., Yang, C., Wu, C., Haung, J., Hong, J., Chiang, C., Huang, C., & Leu, M. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.10.2105 · Cited by 132
Tanaka, Y., Atsumi, Y., Matsuoka, K., Onuma, T., Tohjima, T., & Kawamori, R. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.116 · Cited by 93
Hemoglobin A1c Level and Future Cardiovascular Events Among Women
Blake, G. J., Pradhan, A. D., Manson, J. E., Williams, G. R., Buring, J. E., Ridker, P. M., & Glynn, R. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.7.757 · Cited by 92
Valuing Quality of Life and Improvements in Glycemic Control in People With Type 2 Diabetes
Testa, M. A., Simonson, D. C., & Turner, R. R. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.c44 · Cited by 81
Epidemiology of Dialysis Patients and Heart Failure Patients
Kalantar‐Zadeh, K., Abbott, K. C., Kronenberg, F., Anker, S. D., Horwich, T. B., & Fonarow, G. C. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.09.005 · Cited by 80
Self-citationGlycosylated Hemoglobin and the Risk of Retinopathy in Insulin-Dependent Diabetes Mellitus
Warram, J. H., Manson, J. E., & Królewski, A. S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321915 · Cited by 73
Glycosylated Hemoglobin and Mortality in Patients with Nondiabetic Chronic Kidney Disease
Menon, V., Greene, T., Pereira, A. A., Wang, X., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Sarnak, M. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050552 · Cited by 63
Is there a need to optimize glycemic control in hemodialyzed diabetic patients?
Feldt‐Rasmussen, B. (2006) · Kidney International · doi:10.1038/sj.ki.5001886 · Cited by 42
Diabetes: Changing the Fate of Diabetics in the Dialysis Unit
Broumand, B. (2006) · Blood Purification · doi:10.1159/000096396 · Cited by 42
(2006) · American Journal of Kidney Diseases · doi:10.1053/s0272-6386(05)01820-2 · Cited by 36
Friedman, E. A. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70326-1 · Cited by 26
Chapter 23 Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction
Abbott, K. C., & Bakris, G. L. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39025-3 · Cited by 24
End-stage renal disease in diabetic persons: Is the pandemic subsiding?
Friedman, E. A., Friedman, A. L., & Eggers, P. W. (2006) · Kidney International · doi:10.1038/sj.ki.5001978 · Cited by 15
Glycosylated Hemoglobin and the Risk of Microalbuminuria in Insulin-Dependent Diabetes Mellitus
Chaturvedi, N., & Fuller, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510053331414 · Cited by 14
Cited by
KDOQI clinical practice guideline for diabetes and CKD: 2012 update
(2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.005 · Cited by 1,320
Diabetic kidney disease: a report from an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1296 · Cited by 1,153
Self-citationDiabetic Kidney Disease: A Report From an ADA Consensus Conference
Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.001 · Cited by 890
Self-citationKalantar-Zadeh, K., Regidor, D. L., Kovesdy, C. P., Van Wyck, D., Bunnapradist, S., Horwich, T. B., & Fonarow, G. C. (2009) · Circulation · doi:10.1161/circulationaha.108.807362 · Cited by 542
Self-citationLittle, R. R., Rohlfing, C. L., & Sacks, D. B. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148841 · Cited by 365
Metadata
- Authors
- Kalantar-Zadeh, K., Kopple, J. D., Regidor, D. L., Jing, J., Shinaberger, C. S., Aronovitz, J., McAllister, C. J., Whellan, D., & Sharma, K.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-05-01
- Volume
- 30
- Issue
- 5
- Pages
- 1049-1055
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2141500413
- Cited by
- 254
- References
- 33
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.